Outcomes of laser thermal therapy for recurrent head and neck cancer. 2010

Joel A Sercarz, and Michael Bublik, and Jayne Joo, and Paulo B Paiva, and Kelsy N Areco, and Maria Helena Brandalise, and Christopher Loh, and Michael Masterman-Smith, and Marcos B Paiva
Department of Surgery, Division of Head and Neck Surgery, David Geffen School of Medicine at UCLA, University of California, Los Angeles, CA, USA.

OBJECTIVE To review the outcomes of a phase II study using laser-induced thermal therapy (LITT) as a palliative treatment for 106 patients with recurrent head and neck tumors. METHODS Retrospective study. METHODS Tertiary hospital in the United States. METHODS The primary endpoints were tumor response and survival. Prognostic values were assessed by the Kaplan-Meier method. RESULTS The best results were seen in oral cavity tumors, in which mean survival was 29.1 months, as compared to neck tumors (mean 14.4 +/- 6.9 months; range 7.5-20.7 months; with a 95% confidence interval). Further analysis showed that clinical factors such as gender, smoking, and alcohol use were not indicators of poor prognosis, whereas neck disease and tumor stage at first treatment were relevant factors. CONCLUSIONS In this study, 40 out of 106 patients treated by LITT remained alive at the end of our follow-up, and a complete response was seen in 24 (22.6%) patients. The highest response rate was seen in oral cavity tumors, which suggests that tumor location at this site may be a predictor of favorable outcome with LITT.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009062 Mouth Neoplasms Tumors or cancer of the MOUTH. Cancer of Mouth,Mouth Cancer,Oral Cancer,Oral Neoplasms,Cancer of the Mouth,Neoplasms, Mouth,Neoplasms, Oral,Cancer, Mouth,Cancer, Oral,Cancers, Mouth,Cancers, Oral,Mouth Cancers,Mouth Neoplasm,Neoplasm, Mouth,Neoplasm, Oral,Oral Cancers,Oral Neoplasm
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D010166 Palliative Care Care alleviating symptoms without curing the underlying disease. (Stedman, 25th ed) Palliative Treatment,Palliative Supportive Care,Palliative Surgery,Palliative Therapy,Surgery, Palliative,Therapy, Palliative,Care, Palliative,Palliative Treatments,Supportive Care, Palliative,Treatment, Palliative,Treatments, Palliative
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D005260 Female Females
D006258 Head and Neck Neoplasms Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651) Cancer of Head and Neck,Head Cancer,Head Neoplasm,Head and Neck Cancer,Head and Neck Neoplasm,Neck Cancer,Neck Neoplasm,Neck Neoplasms,Neoplasms, Upper Aerodigestive Tract,UADT Neoplasm,Upper Aerodigestive Tract Neoplasm,Upper Aerodigestive Tract Neoplasms,Cancer of Head,Cancer of Neck,Cancer of the Head,Cancer of the Head and Neck,Cancer of the Neck,Head Neoplasms,Head, Neck Neoplasms,Neoplasms, Head,Neoplasms, Head and Neck,Neoplasms, Neck,UADT Neoplasms,Cancer, Head,Cancer, Neck,Cancers, Head,Cancers, Neck,Head Cancers,Neck Cancers,Neoplasm, Head,Neoplasm, Neck,Neoplasm, UADT,Neoplasms, UADT

Related Publications

Joel A Sercarz, and Michael Bublik, and Jayne Joo, and Paulo B Paiva, and Kelsy N Areco, and Maria Helena Brandalise, and Christopher Loh, and Michael Masterman-Smith, and Marcos B Paiva
October 2013, The Journal of laryngology and otology,
Joel A Sercarz, and Michael Bublik, and Jayne Joo, and Paulo B Paiva, and Kelsy N Areco, and Maria Helena Brandalise, and Christopher Loh, and Michael Masterman-Smith, and Marcos B Paiva
January 2000, Diagnostic and therapeutic endoscopy,
Joel A Sercarz, and Michael Bublik, and Jayne Joo, and Paulo B Paiva, and Kelsy N Areco, and Maria Helena Brandalise, and Christopher Loh, and Michael Masterman-Smith, and Marcos B Paiva
July 2020, Gan to kagaku ryoho. Cancer & chemotherapy,
Joel A Sercarz, and Michael Bublik, and Jayne Joo, and Paulo B Paiva, and Kelsy N Areco, and Maria Helena Brandalise, and Christopher Loh, and Michael Masterman-Smith, and Marcos B Paiva
January 2014, Journal of radiation research,
Joel A Sercarz, and Michael Bublik, and Jayne Joo, and Paulo B Paiva, and Kelsy N Areco, and Maria Helena Brandalise, and Christopher Loh, and Michael Masterman-Smith, and Marcos B Paiva
September 1998, The Laryngoscope,
Joel A Sercarz, and Michael Bublik, and Jayne Joo, and Paulo B Paiva, and Kelsy N Areco, and Maria Helena Brandalise, and Christopher Loh, and Michael Masterman-Smith, and Marcos B Paiva
June 1991, Cancer,
Joel A Sercarz, and Michael Bublik, and Jayne Joo, and Paulo B Paiva, and Kelsy N Areco, and Maria Helena Brandalise, and Christopher Loh, and Michael Masterman-Smith, and Marcos B Paiva
November 2009, Ear, nose, & throat journal,
Joel A Sercarz, and Michael Bublik, and Jayne Joo, and Paulo B Paiva, and Kelsy N Areco, and Maria Helena Brandalise, and Christopher Loh, and Michael Masterman-Smith, and Marcos B Paiva
January 2016, Cancer journal (Sudbury, Mass.),
Joel A Sercarz, and Michael Bublik, and Jayne Joo, and Paulo B Paiva, and Kelsy N Areco, and Maria Helena Brandalise, and Christopher Loh, and Michael Masterman-Smith, and Marcos B Paiva
August 2003, Technology in cancer research & treatment,
Joel A Sercarz, and Michael Bublik, and Jayne Joo, and Paulo B Paiva, and Kelsy N Areco, and Maria Helena Brandalise, and Christopher Loh, and Michael Masterman-Smith, and Marcos B Paiva
January 1989, Dysphagia,
Copied contents to your clipboard!